CJEU hands down SPC guidance in Royalty Pharma
30-04-2020
Questions on Neurim scope remain post-SPC ruling, say lawyers
25-03-2019
nitpicker / Shutterstock.com
The Court of Justice of the European Union (CJEU) yesterday, March 21, handed down a supplementary protection certificate (SPC) decision referred to it by the English High Court.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
CJEU, Court of Justice of the European Union, SPC, supplementary protection certificate, Abraxis, marketing authorisation, English High Court
